Company highlight: St John’s Laboratory

At CiteAb we work hard to get to know individual antibody suppliers so that you can be sure the data we hold is always up to date and correct. Every now and then we feature individual company highlights here on our blog, allowing you to get to know leading antibody suppliers too.

This week we have been speaking to St John’s Laboratory, a new startup antibody company based in London, UK, who have been trading for exactly a year this month!

SJL_logo

St John’s Laboratory was started with the purpose of assisting in bioscience progress by supporting the scientific and medical community with top notch antibodies. Their main concern is being able to supply high quality antibodies that work first time, therefore avoiding loss of time and money.

The company focuses on antibodies for stem cell research, neuroscience research, and cell division and proliferation work. Through a consultancy arm of the business, St John’s Laboratory connects academic researchers with industrial partners and investors for funding and commercialisation.

Speaking on behalf of the company, Mei Yee Leung said: “Our aim as a company is to be socially responsible, and to focus on delivering the very best level of service for our customers.

“We have a small team of four people, and in our first year of business we are pleased with our performance. We are now developing strong collaborations within the industry and with academic partners, and are growing the company both in the UK and internationally.”

Furthermore, Mei Yee Leung added: “Our motto as a company is ‘we do things differently’ and we aim to achieve that in how we operate our business every day. Our team here at St John’s Laboratory is made up of learners who love getting customer feedback that will help develop the company.”

St John’s Laboratory is currently running a scheme that offers free trial size antibodies for third party validation. The full list of free samples is available here.

CiteAb now lists all of St John’s antibodies, see here. We are always looking for new companies and academics to share their antibody data with us, so if you have antibodies that are not listed on CiteAb do get in touch with us.

– Matt and the CiteAb team


Subscribe to the CiteAb Newsletter